LYNK Pharmaceuticals raised $44.1M Series C venture round, led by China Grand Prosperity Investment.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$122.2M
Top Valuation
-
LYNK Pharmaceuticals raised $44.1M in a Series C round.
The round was announced on 09/21/23.
The round was led by China Grand Prosperity Investment.